BCL2L11 and acute myeloid leukemia: BIM is reported to be downregulated by FLT3-ITD by the FOXO3a-dependent transcriptional mechanism and to play a critical role in TKI-induced apoptosis in FLT3-ITD-positive AML cells [52,53].